1.
|
Phase: Phase III Type: Treatment Status: Completed Age: postmenopausal Sponsor: NCI Protocol IDs: E-EB193, CLB-9443, NCCTG-953052, SWOG-9514, INT-0151, NCT00002646
|
|
2.
|
Phase: Phase III Type: Prevention Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: ID92-027, P30CA016672, MDA-ID-92027, NCI-P97-0092, CDR0000065761, NCT00003075
|
|
3.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067387, MDA-ID-95236, NCI-G99-1621, NCI-T98-0051, T98-0051, NCT00004154
|
|
4.
|
Phase: Phase II, Phase I Type: Prevention Status: Completed Age: 50-84 Sponsor: NCI Protocol IDs: MDA-ID-95184, NCI-P97-0099
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: any age Sponsor: NCI Protocol IDs: ICC-88B3, NCI-T89-0087D, T89-0087
|
|
6.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00104, R21CA119519, 6071, UWCC-6071, FHCRC-6071, NCI-6957, 6957, UWCC-UW-6071, UWCC-06-0644-H/A, NCT00288067
|
|
7.
|
Phase: Phase II Type: Prevention, Treatment Status: Completed Age: adult Sponsor: NCI Protocol IDs: SWOG-9460, NCI-P96-0074
|
|
8.
|
Phase: Phase II Type: Prevention Status: Closed Age: 16 and over Sponsor: NCI Protocol IDs: MDA-DM-93018, NCI-P97-0079
|
|
9.
|
Phase: Phase II Type: Prevention Status: Closed Age: Over 18 Sponsor: NCI Protocol IDs: MSGCC-9224, NCI-P97-0098
|
|
10.
|
Phase: Phase II Type: Prevention Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: UAB-9431, NCI-P97-0103
|
|
11.
|
Phase: Phase II Type: Prevention Status: Closed Age: 40 to 75 Sponsor: NCI Protocol IDs: BCM-H2533, NCI-P97-0107
|
|
12.
|
Phase: Phase II Type: Prevention Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: ID94-029, P30CA016672, MDA-ID-94029, NCI-P97-0113, CDR0000065829, NCT00003099
|
|
13.
|
Phase: Phase II Type: Prevention Status: Closed Age: 45 and over Sponsor: NCI Protocol IDs: MSGCC-9215, NCI-P97-0114
|
|
14.
|
Phase: Phase II Type: Prevention Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-2695, UPCC-2600, NCI-P98-0134, NCT00003601
|
|
15.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067401, UAB-9713, NCI-G99-1626, NCT00004161
|
|
16.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NABTC-9905, UCLA-0006094, NCT00006080
|
|
17.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: ID99-334, U01CA070172, P30CA016672, MDA-ID-99334, NCI-610, CDR0000068294, 610, NCT00006471
|
|
18.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CCUM-9940, NCI-T99-0112, NCT00009971, T99-0112
|
|
19.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068465, WSU-C-2232, NCI-WSU-910, NCT00011973
|
|
20.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068985, P30CA014089, CCC-PHII-25, LAC-USC-5GYN003, NCI-19, 19, NCT00026091
|
|
21.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-92-C-0231D, NCI-MB-299, NCI-T92-0082N, T92-0082
|
|
22.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: MDA-DM-92037, NCI-T92-0113C, T92-0113
|
|
23.
|
Phase: Phase II Type: Prevention Status: Closed Age: 18 and over Sponsor: Protocol IDs: WSU-C-1001, NCI-P93-0035
|
|
24.
|
Phase: Phase II Type: Treatment Status: Completed Age: 21 and under at original diagnosis Sponsor: NCI Protocol IDs: COG-ANBL0321, COG-ADVL0024, COG-A0996, NCT00053326, ANBL0321
|
|
25.
|
Phase: Phase II Type: Prevention, Treatment Status: Completed Age: Not specified Sponsor: NCI Protocol IDs: CNR-IEO-007, U01-CA77188-01
|